Alaunos Therapeutics, Inc. (TCRT) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-06-29 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-05-26 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-05-18 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-04-15 | 8-K | Listing Notice | SEC |
| 2026-03-02 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-01-08 | 8-K | Termination of Agreement, Item 3.03, Other Events, Financial Statements & Exhibits | SEC |
| 2025-12-23 | 8-K | Other Events | SEC |
| 2025-08-20 | 8-K | Other Events | SEC |
| 2025-07-22 | 8-K | Officer / Director Changes | SEC |
| 2025-07-17 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-07-10 | 8-K | Item 3.03, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-07-02 | 8-K | Listing Notice, Officer / Director Changes | SEC |
| 2025-06-26 | 8-K | Material Agreement, Unregistered Sales, Item 3.03, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-06-26 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-06-10 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-05-23 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-04-18 | 8-K | Officer / Director Changes | SEC |
| 2025-04-15 | 8-K | Officer / Director Changes | SEC |
| 2025-04-14 | 8-K | Material Agreement, Termination of Agreement, Unregistered Sales, Item 3.03, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-04-11 | 8-K | Listing Notice, Other Events | SEC |
| 2024-10-10 | 8-K | Termination of Agreement, Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-07-16 | 8-K | Other Events | SEC |
| 2024-07-16 | 8-K | Charter Amendments | SEC |
| 2024-06-21 | 8-K | Auditor Change, Financial Statements & Exhibits | SEC |
| 2024-06-12 | 8-K | Item 3.03, Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-02-22 | 8-K | Officer / Director Changes | SEC |
| 2024-02-20 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-02-01 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2024-01-29 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-01-22 | 8-K | Officer / Director Changes | SEC |
| 2024-01-02 | 8-K | Officer / Director Changes, Reg FD Disclosure | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.